20/20 Biolabs gets Nasdaq notice over $2.5m stockholders’ equity rule
On Sept. 3, 2026, 20/20 Biolabs received a Nasdaq notice that it failed the $2.5 million stockholders’ equity requirement. The company has 45 days to submit a compliance plan and may receive up to 180 days to regain compliance if accepted.